Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer

European Journal of Cancer Care

Volumn 26, Issue 4, 2017, Pages

  Wang, W ^a,b   Qu, A ^a   Liu, W ^a   Liu, Y ^a   Zheng, G ^a   Du, L ^a   Zhang, X ^a   Yang, Y ^a   Wang, C ^a   Chen, X ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

biomarker; colorectal cancer; diagnosis; miR 210; prognosis

Indexed keywords

MICRORNA; MIRN210 MICRORNA, HUMAN; TUMOR MARKER;

AGED; AREA UNDER THE CURVE; COLON TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; RECTUM TUMOR; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AREA UNDER CURVE; BIOMARKERS, TUMOR; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84958719023     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/ecc.12448     Document Type: Article

References (31)

1. Akobeng A.K. (2007) Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatrica 96, 644–647.
2. Asaga S., Kuo C., Nguyen T., Terpenning M., Giuliano A.E. & Hoon D.S. (2011) Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clinical Chemistry 57, 84–91.
3. Bartel D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233.
4. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J. & Zhang C.Y. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 18, 997–1006.
5. Chen T.S., Lai R.C., Lee M.M., Choo A.B., Lee C.N. & Lim S.K. (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Research 38, 215–224.
6. Dang K. & Myers K.A. (2015) The role of hypoxia-induced miR-210 in cancer progression. International Journal of Molecular Sciences 16, 6353–6372.
7. Fakih M.G. & Padmanabhan A. (2006) CEA monitoring in colorectal cancer. What you should know. Oncology 20, 579–587; discussion 588, 594, 596 passim.
8. Guo S., Bai R., Liu W., Zhao A., Zhao Z., Wang Y., Wang Y., Zhao W. & Wang W. (2015) MicroRNA210 is upregulated by hypoxia-inducible factor1 alpha in the stromal cells of giant cell tumours of bone. Molecular Medicine Reports 12, 6518–6592.
9. Ho A.S., Huang X., Cao H., Christman-Skieller C., Bennewith K., Le Q.T. & Koong A.C. (2010) Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Translational Oncology 3, 109–113.
10. Iwamoto H., Kanda Y., Sejima T., Osaki M., Okada F. & Takenaka A. (2014) Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma. International Journal of Oncology 44, 53–58.
11. Jemal A., Bray F., Center M.M., Ferlay J., Ward E. & Forman D. (2011) Global cancer statistics. CA: A Cancer Journal for Clinicians 61, 69–90.
12. Jung E.J., Santarpia L., Kim J., Esteva F.J., Moretti E., Buzdar A.U., Di Leo A., Le X.F., Bast R.C. Jr, Park S.T., Pusztai L. & Calin G.A. (2012) Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumour presence in breast cancer patients. Cancer 118, 2603–2614.
13. Ke Z. & Zhang C.Y. (2012) Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Medicinal Research Reviews 32, 326–348.
14. Kraus S., Nabiochtchikov I., Shapira S. & Arber N. (2014) Recent advances in personalized colorectal cancer research. Cancer Letters 347, 15–21.
15. Lai N.S., Wu D.G., Fang X.G., Lin Y.C., Chen S.S., Li Z.B. & Xu S.S. (2015) Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma. British Journal of Cancer 112(Suppl.), 000–000.
16. Li L., Huang K., You Y., Fu X., Hu L., Song L. & Meng Y. (2014) Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis. International Journal of Oncology 44, 2111–2120.
17. Madhavan D., Zucknick M., Wallwiener M., Cuk K., Modugno C., Scharpff M., Schott S., Heil J., Turchinovich A., Yang R., Benner A., Riethdorf S., Trumpp A., Sohn C., Pantel K., Schneeweiss A. & Burwinkel B. (2012) Circulating miRNAs as surrogate markers for circulating tumour cells and prognostic markers in metastatic breast cancer. Clinical Cancer Research 18, 5972–5982.
18. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B. & Tewari M. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 105, 10513–10518.
19. Noman M.Z., Janji B., Hu S., Wu J.C., Martelli F., Bronte V. & Chouaib S. (2015) Tumour-promoting effects of myeloid-derived suppressor cells are potentiated by hypoxia-induced expression of miR-210. Cancer Research 75, 3771–3787.
20. Osugi J., Kimura Y., Owada Y., Inoue T., Watanabe Y., Yamaura T., Fukuhara M., Muto S., Okabe N., Matsumura Y., Hasegawa T., Yonechi A., Hoshino M., Higuchi M., Shio Y., Suzuki H. & Gotoh M. (2015) Prognostic impact of hypoxia-inducible miRNA-210 in patients with lung adenocarcinoma. Journal of Oncology 2015, 316745.
21. Pigati L., Yaddanapudi S.C., Iyengar R., Kim D.J., Hearn S.A., Danforth D., Hastings M.L. & Duelli D.M. (2010) Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5, e13515.
22. Qu A., Du L., Yang Y., Liu H., Li J., Wang L., Liu Y., Dong Z., Zhang X., Jiang X., Wang H., Li Z., Zheng G. & Wang C. (2014) Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer. PLoS ONE 9, e90952.
23. Samaan S., Khella H.W.Z., Girgis A., Scorilas A., Lianidou E., Gabril M., Krylov S.N., Jewett M., Bjarnason G.A. & El-Said H. (2015) miR-210 is a prognostic marker in clear cell renal cell carcinoma. Journal of Molecular Diagnostics 17, 136–144.
24. Shang C., Hong Y., Guo Y., Liu Y.H. & Xue Y.X. (2014) MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 20, 2571–2577.
25. Siegel R., Naishadham D. & Jemal A. (2012) Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 62, 10–29.
26. Tan E., Gouvas N., Nicholls R.J., Ziprin P., Xynos E. & Tekkis P.P. (2009) Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surgical Oncology 18, 15–24.
27. Tse A.C., Li J.W., Chan T.F., Wu R.S. & Lai K.P. (2015) Hypoxia induces miR-210, leading to anti-apoptosis in ovarian follicular cells of marine medaka Oryzias melastigma. Aquatic Toxicology 165, 189–196.
28. Yanaka Y., Muramatsu T., Uetake H., Kozaki K.I. & Inazawa J. (2015) miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer. Carcinogenesis 36, 1363–1371.
29. Yang Y., Qu A., Liu J., Wang R., Liu Y., Li G., Duan W., Fang Q., Jiang X. & Wang L. (2015) Serum miR-210 contributes to tumour detection, stage prediction and dynamic surveillance in patients with bladder cancer. PLoS ONE 10, e0135168.
30. Ying Q., Liang L., Guo W., Zha R., Tian Q., Huang S., Yao J., Ding J., Bao M., Ge C., Yao M., Li J. & He X. (2011) Hypoxia-inducible microRNA-210 augments the metastatic potential of tumour cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology (Baltimore, MD) 54, 2064–2075.
31. Zheng G., Wang H., Zhang X., Yang Y., Wang L., Du L., Li W., Li J., Qu A., Liu Y. & Wang C. (2013) Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS ONE 8, e83025.